Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Natural T-cell ligands that are created by genetic variants can be transferred between cells by extracellular vesicles.

Kremer AN, Zonneveld MI, Kremer AE, van der Meijden ED, Falkenburg JHF, Wauben MHM, Nolte-'t Hoen ENM, Griffioen M.

Eur J Immunol. 2018 Oct;48(10):1621-1631. doi: 10.1002/eji.201747152. Epub 2018 Aug 17.

2.

Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2.

Pont MJ, van der Lee DI, van der Meijden ED, van Bergen CA, Kester MG, Honders MW, Vermaat M, Eefting M, Marijt EW, Kielbasa SM, Hoen PA, Falkenburg JH, Griffioen M.

Clin Cancer Res. 2016 Aug 15;22(16):4185-96. doi: 10.1158/1078-0432.CCR-15-2307. Epub 2016 Mar 10.

3.

Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies.

Kremer AN, van der Meijden ED, Honders MW, Pont MJ, Goeman JJ, Falkenburg JH, Griffioen M.

Biol Blood Marrow Transplant. 2014 May;20(5):742-7. doi: 10.1016/j.bbmt.2014.02.005. Epub 2014 Feb 14.

4.

Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.

Kremer AN, van der Griendt JC, van der Meijden ED, Honders MW, Ayoglu B, Schwenk JM, Nilsson P, Falkenburg JH, Griffioen M.

Haematologica. 2014 Feb;99(2):365-9. doi: 10.3324/haematol.2013.086652. Epub 2013 Oct 4.

5.

Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.

Kremer AN, van der Meijden ED, Honders MW, Goeman JJ, Wiertz EJ, Falkenburg JH, Griffioen M.

Blood. 2012 Oct 18;120(16):3246-55. doi: 10.1182/blood-2011-12-399311. Epub 2012 Aug 13.

6.

Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.

Griffioen M, Honders MW, van der Meijden ED, van Luxemburg-Heijs SA, Lurvink EG, Kester MG, van Bergen CA, Falkenburg JH.

Haematologica. 2012 Aug;97(8):1196-204. doi: 10.3324/haematol.2011.049478. Epub 2012 Mar 14.

7.

High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.

Van Bergen CA, Rutten CE, Van Der Meijden ED, Van Luxemburg-Heijs SA, Lurvink EG, Houwing-Duistermaat JJ, Kester MG, Mulder A, Willemze R, Falkenburg JH, Griffioen M.

Cancer Res. 2010 Nov 15;70(22):9073-83. doi: 10.1158/0008-5472.CAN-10-1832. Epub 2010 Nov 9.

8.

HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.

Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R, Falkenburg JH.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1282-92. doi: 10.1016/j.bbmt.2010.03.018. Epub 2010 Mar 27.

9.

Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro.

Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R, Falkenburg JH.

Blood. 2010 Jan 7;115(1):151-3. doi: 10.1182/blood-2009-10-249821. No abstract available.

10.

Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.

Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M.

Blood. 2009 Oct 22;114(17):3684-92. doi: 10.1182/blood-2009-03-208017. Epub 2009 Aug 25.

11.

Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.

Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SA, von dem Borne PA, van Rood JJ, Willemze R, Falkenburg JH.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3837-42. doi: 10.1073/pnas.0712250105. Epub 2008 Mar 3.

12.

Metabolomic differentiation of Brassica rapa following herbivory by different insect instars using two-dimensional nuclear magnetic resonance spectroscopy.

Widarto HT, Van Der Meijden E, Lefeber AW, Erkelens C, Kim HK, Choi YH, Verpoorte R.

J Chem Ecol. 2006 Nov;32(11):2417-28.

PMID:
17080307
13.

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.

Slager EH, Honders MW, van der Meijden ED, van Luxemburg-Heijs SA, Kloosterboer FM, Kester MG, Jedema I, Marijt WA, Schaafsma MR, Willemze R, Falkenburg JH.

Blood. 2006 Jun 15;107(12):4954-60. Epub 2006 Feb 23.

14.

Do distances among host patches and host density affect the distribution of a specialist parasitoid?

Esch S, Klinkhamer PG, van der Meijden E.

Oecologia. 2005 Dec;146(2):218-26. Epub 2005 Oct 28.

PMID:
16096845
15.

Comparing metabolomes: the chemical consequences of hybridization in plants.

Kirk H, Choi YH, Kim HK, Verpoorte R, van der Meijden E.

New Phytol. 2005 Aug;167(2):613-22.

16.

A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.

van de Corput L, Chaux P, van der Meijden ED, De Plaen E, Frederik Falkenburg JH, van der Bruggen P.

Leukemia. 2005 Feb;19(2):279-85.

PMID:
15526018
17.

Clonally expanded T cells in hairy cell leukemia patients are not leukemia specific.

Spaenij-Dekking EH, Van der Meijden ED, Falkenburg JH, Kluin-Nelemans JC.

Leukemia. 2004 Jan;18(1):176-8. No abstract available.

PMID:
14523468
18.

Diversity of pyrrolizidine alkaloids in Senecio species does not affect the specialist herbivore Tyria jacobaeae.

Macel M, Klinkhamer PG, Vrieling K, van der Meijden E.

Oecologia. 2002 Dec;133(4):541-550. doi: 10.1007/s00442-002-1074-6. Epub 2002 Dec 1.

PMID:
28466158
19.

Induced responses in three alkaloid-containing plant species.

van Dam NM, van der Meijden E, Verpoorte R.

Oecologia. 1993 Sep;95(3):425-430. doi: 10.1007/BF00320998.

PMID:
28314020

Supplemental Content

Loading ...
Support Center